/Investor DB

Johnson & Johnson Innovation – JJDC — 2022 Investments

6 investments dated 2022 · listed companies and verified rows first · show all

Cornerstone AIcornerstone.aiinSeed · Jul 2022 · $5M

Cornerstone provides expert-guided AI software that organizes, standardizes, and harmonizes life science data from clinical trials, labs, and EHRs to produce analysis-ready datasets.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtech

Andrew Howland(Founder)inClara Oromendia(Founder)inViraj NarayananinMichael Elashoff(Founder)

Co-investorsAcrew CapitalHealthy VenturesInitiate Venture Partners

HistoSonicshistosonics.comin𝕏Dec 2022 · $85M

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.

BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB

Thomas Davison(Executive Officer, Director)inM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)

Co-investorsAlpha JWC VenturesAlpha Wave GlobalAmzak HealthArboretum VenturesClarevia VenturesEarly Stage Partners, LP+9 more

Pulmocidepulmocide.cominDec 2022 · $52M

Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.

BiotechHealthtech

Pete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDavid Mantusin

Co-investorsAdjuvant CapitalAsahi Kasei Corporate Venture CapitalDementia Discovery FundF-Prime CapitalJeito CapitalLongwood Fund+4 more

Rondo Therapeuticsrondotx.cominMar 2022 · $67M

Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.

BiotechHealthtech

Shelley Force Aldred(Co-Founder & Chief Executive Officer)inNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)

Co-investorsCanaan PartnersDementia Discovery FundRed Tree VentureSV Health InvestorsNovo Holdings

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Metaphysic AIPerceive Biotherapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.